The optimum duration of combination androgen deprivation therapy (ADT) with prostate cancer radiotherapy: Determining the duration-benefit relationship from multi-institutional analysis 50th Annual Meeting of the American-Society-for-Therapeutic-Radiology-and-Oncology (ASTRO) Pickles, T., Williams, S. G., Buyyounouski, M. K., Kestin, L. L., Duchesne, G. M. ELSEVIER SCIENCE INC. 2008: S73–S73

View details for Web of Science ID 000258805300164